Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
US veterinary drug compounding firms Wedgewood Pharmacy and Diamondback Drugs have agreed to a merger.
Animal Pharm is looking for new authors for its animal health industry reports team.
New research has outlined the potential of repurposing common veterinary antiparasiticides for the control of human vector-borne diseases.
US firm Immucell has addressed a backlog of orders for its First Defense product line against calf scours.
Boehringer Ingelheim Vetmedica has gained a supplemental US approval for Cystorelin (gonadorelin), which is used in reproductive synchrony programs for cattle.
Agriculture Committee members of the European Parliament (MEPs) have given the green light to new rules regarding medicated feed and antimicrobial resistance (AMR).
US pet therapeutics company Kindred Biosciences has become a commercial entity around six years after it was founded.
UK firm Animalcare has pencilled a fourth-quarter launch date for its recently-approved Cortacare canine dermatology product.
Animal Ethics has extended the use of its Tri-Solfen pain relief product to calves through a new Australian approval.
Dutch animal nutrition business Nutreco has invested in young Israeli company ViAqua to aid development of a treatment that improves resistance to viral diseases in shrimp.
Boehringer Ingelheim Animal Health has secured Japanese approval for Zactran (gamithromycin) as an antibiotic treatment of swine respiratory disease.
Australian firm CannPal Therapeutics has signed a research agreement with Eurofins Animal Health to develop a cannabis-derived pain therapeutic for cats.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.